opeartes as a tech-forward, diversified, multi-jurisdictional high-growth entity capitalizing on emerging opportunities across real estate development, digital asset innovation and reproductive health solutions. The company is headquartered in Bangkok, Bangkok Metropolis and currently employs 87 full-time employees. The company went IPO on 2022-02-15. The firm operates through three business divisions, which include NewGenProperty, which operates real estate development projects in the United Arab Emirates (UAE)'s Ras Al Khaimah Emirate; NewGenDigital, which serves as the Company's digital asset and decentralized finance (DeFi) solutions arm, and NewGenSup, which focuses on health and longevity products and solutions. Its legacy business involves providing in-vitro fertilization (IVF) and assisted reproductive treatment services, such as surrogacy and egg freezing across Asia.
NewGenIvf Group Ltd'in temel mali tabloları nelerdir?
Son mali tabloya (Form-10K) göre, NewGenIvf Group Ltd'in toplam varlıkları $0 olup, net 亏损 $0'dir.
NIVF'ün temel finansal oranları nelerdir?
NewGenIvf Group Ltd'in cari oranı 0, net kâr marjı 0, hisse başına satış $0'dir.
NewGenIvf Group Ltd'in geliri segment veya coğrafya bazında nasıl dağılıyor?
NewGenIvf Group Ltd 最大收入来源是 In Vitro Fertilization Treatment Service,在最近的收益报告中收入为 3,905,863。就地区而言, Kyrgyzstan 是 NewGenIvf Group Ltd 的主要市场,收入为 2,312,348。
NewGenIvf Group Ltd kârlı mı?
否, son mali tablolara göre NewGenIvf Group Ltd'in net 亏损 $0'dir.
NewGenIvf Group Ltd'in herhangi bir yükümlülüğü var mı?
否, NewGenIvf Group Ltd'in yükümlülüğü 0'dir.
NewGenIvf Group Ltd'in tedavüldeki hisse sayısı kaçtır?
NewGenIvf Group Ltd'in toplam tedavüldeki hisse sayısı 0'dir.